{"id":"https://openalex.org/W1911089380","doi":"https://doi.org/10.1002/oby.20356","title":"Ascending dose\u2010controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women","display_name":"Ascending dose\u2010controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-25","ids":{"openalex":"https://openalex.org/W1911089380","doi":"https://doi.org/10.1002/oby.20356","mag":"1911089380","pmid":"https://pubmed.ncbi.nlm.nih.gov/23512440"},"language":"en","primary_location":{"id":"doi:10.1002/oby.20356","doi":"https://doi.org/10.1002/oby.20356","is_oa":false,"landing_page_url":"https://doi.org/10.1002/oby.20356","pdf_url":null,"source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1911089380"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101818170","display_name":"Thomas E. Hughes","orcid":"https://orcid.org/0000-0003-0554-427X","observed_orcids":["https://orcid.org/0000-0003-0554-427X"]},"institutions":[{"id":"https://openalex.org/I4210159657","display_name":"Zafgen (United States)","ror":"https://ror.org/05035d657","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159657"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"T. E. Hughes","raw_affiliation_strings":["Zafgen, Inc., Cambridge, MA, USA","Funding agency: This study was funded by Zafgen, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zafgen, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210159657"]},{"raw_affiliation_string":"Funding agency: This study was funded by Zafgen, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055583882","display_name":"D. D. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159657","display_name":"Zafgen (United States)","ror":"https://ror.org/05035d657","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159657"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. D. Kim","raw_affiliation_strings":["Zafgen, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zafgen, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210159657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021649243","display_name":"Joanne K. Marjason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097201","display_name":"Q-Pharm","ror":"https://ror.org/0135q5188","country_code":"AU","type":"other","lineage":["https://openalex.org/I4210097201"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Marjason","raw_affiliation_strings":["QPharm Ltd., Herson, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QPharm Ltd., Herson, Queensland, Australia","institution_ids":["https://openalex.org/I4210097201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043560888","display_name":"Joseph Proietto","orcid":"https://orcid.org/0000-0002-8517-2076","observed_orcids":["https://orcid.org/0000-0002-8517-2076"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Proietto","raw_affiliation_strings":["University of Melbourne, Heidelberg, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Melbourne, Heidelberg, Victoria, Australia","institution_ids":["https://openalex.org/I165779595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046558354","display_name":"Jonathan P. Whitehead","orcid":"https://orcid.org/0000-0003-3978-3148","observed_orcids":["https://orcid.org/0000-0003-3978-3148"]},"institutions":[{"id":"https://openalex.org/I4210092543","display_name":"Mater Research","ror":"https://ror.org/00nx6aa03","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210092543"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. P. Whitehead","raw_affiliation_strings":["Mater Medical Research Institute, South Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mater Medical Research Institute, South Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I4210092543"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054751943","display_name":"James E. Vath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159657","display_name":"Zafgen (United States)","ror":"https://ror.org/05035d657","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159657"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. E. Vath","raw_affiliation_strings":["Zafgen, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zafgen, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210159657"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5101818170"],"corresponding_institution_ids":["https://openalex.org/I4210159657"],"apc_list":{"value":4980,"currency":"USD","value_usd":4980},"apc_paid":null,"fwci":5.5532,"has_fulltext":false,"cited_by_count":70,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96514277,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"21","issue":"9","first_page":"1782","last_page":"1788"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.671999990940094},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9300000071525574},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7879999876022339},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7250000238418579},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9549999833106995},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9919999837875366},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.8949999809265137},{"id":"https://openalex.org/keywords/fgf21","display_name":"FGF21","score":0.9639999866485596},{"id":"https://openalex.org/keywords/obese-women","display_name":"obese women","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7967745065689087},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7909188270568848},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.7846418619155884},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.7831916809082031},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6847696304321289},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6619935035705566},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.613673210144043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5993713140487671},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5546860098838806},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46277937293052673},{"id":"https://openalex.org/C2780613262","wikidata":"https://www.wikidata.org/wiki/Q223739","display_name":"Leptin","level":3,"score":0.4294854402542114},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.37159818410873413},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2709258794784546},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.06685858964920044},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000626","descriptor_name":"Aminopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D001230","descriptor_name":"Aspergillus","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005346","descriptor_name":"Fibroblast Growth Factors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006815","descriptor_name":"Hunger","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020155","descriptor_name":"3-Hydroxybutyric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020738","descriptor_name":"Leptin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D052242","descriptor_name":"Adiponectin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D063208","descriptor_name":"Methionyl Aminopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/oby.20356","doi":"https://doi.org/10.1002/oby.20356","is_oa":false,"landing_page_url":"https://doi.org/10.1002/oby.20356","pdf_url":null,"source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},{"id":"pmid:23512440","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23512440","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity (Silver Spring, Md.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1974550903","https://openalex.org/W1977870045","https://openalex.org/W1983150723","https://openalex.org/W1991778481","https://openalex.org/W1992860556","https://openalex.org/W1999239339","https://openalex.org/W2028904367","https://openalex.org/W2031889037","https://openalex.org/W2046859247","https://openalex.org/W2050070442","https://openalex.org/W2053380373","https://openalex.org/W2053575156","https://openalex.org/W2058533641","https://openalex.org/W2062707154","https://openalex.org/W2068095019","https://openalex.org/W2098387318","https://openalex.org/W2107257265","https://openalex.org/W2116226868","https://openalex.org/W2134362869","https://openalex.org/W2148287957","https://openalex.org/W2152423343","https://openalex.org/W2167222546","https://openalex.org/W2241709104","https://openalex.org/W3172478362"],"related_works":["https://openalex.org/W2145668345","https://openalex.org/W2876920643","https://openalex.org/W2071956747","https://openalex.org/W2593570932","https://openalex.org/W2618318751","https://openalex.org/W2066741032","https://openalex.org/W2086432736","https://openalex.org/W2793860849","https://openalex.org/W2041376729","https://openalex.org/W202057983"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Evaluate":[1],"the":[2,181],"safety":[3],"and":[4,52,65,68,133,150,155,164,174,188,199,205,211],"tolerability":[5],"of":[6,86,167,184],"beloranib,":[7],"a":[8,147],"fumagillin-class":[9],"methionine":[10],"aminopetidase-2":[11],"(MetAP2)":[12],"inhibitor,":[13],"in":[14,153,161,170,207],"obese":[15,24],"women":[16,29],"over":[17],"4":[18,45,100],"weeks.":[19],"DESIGN":[20],"AND":[21],"METHODS:":[22],"Thirty-one":[23],"(mean":[25],"BMI":[26],"38":[27],"kg/m2)":[28],"were":[30,59,90,178,191],"randomized":[31],"to":[32,139],"intravenous":[33],"0.1,":[34],"0.3,":[35],"or":[36,40],"0.9":[37,106],"mg/m2":[38,107,135],"beloranib":[39,75,108,136],"placebo":[41,123],"twice":[42],"weekly":[43],"for":[44,82,131],"weeks":[46],"(N":[47],"=":[48,117,127],"7,":[49],"6,":[50],"9,":[51],"9).":[53],"RESULTS:":[54],"The":[55,78],"most":[56,79],"frequent":[57],"AEs":[58],"headache,":[60],"infusion":[61,69],"site":[62,70],"injury,":[63],"nausea,":[64],"diarrhea.":[66],"Nausea":[67],"injury":[71],"occurred":[72],"more":[73],"with":[74,105,122,146,180,201],"than":[76],"placebo.":[77,140],"common":[80],"reason":[81],"discontinuation":[83],"was":[84,109,137,144,196],"loss":[85,104,204],"venous":[87],"access.":[88],"There":[89],"no":[91],"clinically":[92],"significant":[93,148],"abnormal":[94],"laboratory":[95],"findings.":[96],"In":[97],"subjects":[98],"completing":[99],"weeks,":[101],"median":[102],"weight":[103,203],"-3.8":[110],"kg":[111,121],"(95%":[112],"CI":[113],"-5.1,":[114],"-0.9;":[115],"N":[116,126],"8)":[118],"versus":[119],"-0.6":[120],"(-4.5,":[124],"-0.1;":[125],"6).":[128],"Weight":[129],"change":[130],"0.1":[132],"0.3":[134],"similar":[138],"Beloranib":[141,194],"(0.9":[142],"mg/m2)":[143],"associated":[145,200],"42":[149],"18%":[151],"reduction":[152],"triglycerides":[154],"LDL-cholesterol,":[156],"as":[157,159],"well":[158,197],"improvement":[160],"C-reactive":[162,209],"protein":[163],"reduced":[165],"sense":[166],"hunger.":[168],"Changes":[169],"\u03b2-hydroxybutyrate,":[171],"adiponectin,":[172],"leptin,":[173],"fibroblast":[175],"growth":[176],"factor-21":[177],"consistent":[179],"putative":[182],"mechanism":[183],"MetAP2":[185],"inhibition.":[186],"Glucose":[187],"blood":[189],"pressure":[190],"unchanged.":[192],"CONCLUSIONS:":[193],"treatment":[195],"tolerated":[198],"rapid":[202],"improvements":[206],"lipids,":[208],"protein,":[210],"adiponectin.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1911089380","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
